Key Information
Source
The Bridge, an hATTR amyloidosis resource from Alnylam Pharmaceuticals, Inc.
Year
2022
summary/abstract
hATTR amyloidosis is an inherited condition, and each child of one parent with hATTR amyloidosis has a 50% chance of inheriting the genetic variant, or change, that causes this condition. This change in the transthyretin (TTR) gene may also be referred to as a mutation. Although anyone can be at risk for this disease, it is more common in certain ethnicities, such as people of African, Brazilian, French, Irish, Japanese, Portuguese, and Swedish descent.
Abstract Source
https://www.hattrbridge.com/sites/default/files/pdfs/Introduction-hATTR-Amyloidosis.pdf